Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-11-14 12:26Core Viewpoint - The stock of Steady Medical (300888) has experienced a decline of 2.25% as of November 14, 2025, with significant net outflows from major and retail investors, while the company shows strong financial performance in its recent quarterly report [1][2][3]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main revenue of 7.897 billion yuan, a year-on-year increase of 30.1% [3] - The net profit attributable to shareholders was 732 million yuan, up 32.36% year-on-year [3] - The third quarter alone saw a main revenue of 2.601 billion yuan, a 27.71% increase year-on-year, and a net profit of 240 million yuan, reflecting a 42.11% rise [3] - The company’s gross margin stands at 48.32%, which is higher than the industry average of 42.35% [3] Market Position - Steady Medical has a total market capitalization of 24.493 billion yuan, ranking 4th in the beauty and personal care industry [3] - The company leads the industry with a net asset value of 12.263 billion yuan, significantly above the industry average of 3.361 billion yuan [3] - The price-to-earnings ratio (P/E) is 25.1, which is lower than the industry average of 39.28, indicating a potentially undervalued stock [3] Investor Sentiment - In the last 90 days, 21 institutions have rated the stock, with 17 buy ratings and 4 hold ratings, suggesting positive sentiment among analysts [4] - The average target price set by institutions over the past 90 days is 5.479 billion yuan, indicating potential upside from the current trading price [4]